KCNN4 and autosomal dominant polycystic kidney disease: The prevention of edema is somewhat reminiscent of the reported reduction in in-vitro cyst formation by kidney cells from patients with autosomal-dominant polycystic kidney disease with a KCa3.1 blocker [25].